Search

Obtenga información sobre el programa de observación activa de MSK para el cáncer de tiroides papilar, que permite a muchas personas evitar cirugías innecesarias y los riesgos que estas tienen.

… Wednesday, November 13, 2024 Los avances en la detección del cáncer han salvado muchas vidas, pero tienen una desventaja importante: algunos casos de cáncer se están sobrediagnosticando, lo que puede llevar a tratar innecesariamente tumores que no habrían representado una amenaza si se hubieran dejado

Though questions remain about how best to use genetic testing for cancer, the trend is toward more inclusive criteria.

… Tuesday, October 22, 2019 Summary Clinical genetics experts see value in testing more women for BRCA mutations. These days, anyone with an interest and about $100 can spit into a tube, mail it to a genetic testing company, and get back details on their DNA. This is known to some as recreational genomics

Decades of research have shown that cancer survival outcomes can vary widely depending on where patients receive care. But efforts to rank hospitals by long-term survival rates have been hindered by the readily available administrative data derived from Medicare claims, which lacks information about cancer stage. Two hospitals providing equally good care may have different survival rates if one hospital treats sicker patients, for example.

… Thursday, October 8, 2015 Decades of research have shown that cancer survival outcomes can vary widely depending on where patients receive care. But efforts to rank hospitals by long-term survival rates have been hindered by the readily available administrative data derived from Medicare claims, which

Early CD4+ T cell reconstitution predicted non-relapsing mortality and overall survival in pediatric patients who received an allogeneic hematopoietic stem cell transplant (HCT) and developed acute graft-versus-host disease.

… Thursday, January 14, 2021 Early CD4+ T cell reconstitution predicted non-relapsing mortality and overall survival (OS) in pediatric patients who received an allogeneic hematopoietic stem cell transplant (HCT) and developed acute graft-versus-host disease (GVHD), according to our research published recently

Memorial Sloan Kettering Cancer Center will recognize three young investigators for their exceptional bodies of innovative work that has helped to advance the field of cancer research. The researchers will receive the Paul Marks Prize for Cancer Research, an award presented biennially by Memorial Sloan Kettering to honor promising scientists under the age of 46.

… Tuesday, September 20, 2011 Memorial Sloan Kettering Cancer Center will recognize three young investigators for their exceptional bodies of innovative work that has helped to advance the field of cancer research. The researchers will receive the Paul Marks Prize for Cancer Research, an award presented

Uniting MSK’s research and clinical expertise with AWS’s advanced cloud technologies is a bold step towards addressing one of the world’s most pressing health challenges.

… Monday, March 10, 2025 Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN) and Memorial Sloan Kettering Cancer Center (MSK), a leading global cancer center, today announced a collaboration harnessing the power of artificial intelligence (AI), high performance computing (HPC), and other

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Wednesday, September 16, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Forbes Names Memorial Sloan Kettering Cancer Center #2 Best Employer in New York State Memorial Sloan Kettering Cancer Center MSK was named the second-best employer in New York

The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD, Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes of Health Director’s New Innovator Award, has served as host for past sessions of the online seminar series for the scientific community.

… Monday, May 4, 2020 The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD , Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes

Researchers shed light on how aberrant cell division can cause the kind of mutations often found in cancer cells.

… Thursday, August 27, 2020 VIDEO | 00:16 Separation Anxiety: Cell Division Gone Awry Leads to Genetic Chaos This video shows the effects of telomere crisis during cell division. As a cell attempts to divide, a tug-of-war develops over the chromosome (narrow strand) as each daughter cell tries to claim

An MSK research team aims to find new ways to stop the most common and deadly form of ovarian cancer — high-grade serous ovarian cancer — from recurring with the help of a method they developed for tracking the evolution of treatment resistant cells in ovarian cancer using blood tests.

… Wednesday, October 1, 2025 Several factors make  ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a microscopic level within the abdomen early on, resulting in diagnosis at an advanced stage. Additionally, while initial treatments with surgery, chemotherapy